80_FR_15688 80 FR 15632 - Bulk Manufacturer of Controlled Substances Application: Penick Corporation

80 FR 15632 - Bulk Manufacturer of Controlled Substances Application: Penick Corporation

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 56 (March 24, 2015)

Page Range15632-15632
FR Document2015-06734

Federal Register, Volume 80 Issue 56 (Tuesday, March 24, 2015)
[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15632]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06734]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Penick 
Corporation

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before May 26, 2015.

ADDRESSES:  Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152. Request for 
hearings should be sent to: Drug Enforcement Administration, Attention: 
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Deputy Assistant Administrator of the DEA Office of Diversion 
Control (``Deputy Assistant Administrator'') pursuant to section 7 of 
28 CFR part 0, appendix to subpart, R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
February 26, 2014, Penick Corporation, 33 Industrial Park Road, 
Pennsville, New Jersey 08070, applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

 
------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Ecgonine (9180)............................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Oripavine (9330)...........................  II
Thebaine (9333)............................  II
Opium tincture (9630)......................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances as bulk controlled substance intermediates for distribution 
to its customers.

    Dated: March 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-06734 Filed 3-23-15; 8:45 am]
BILLING CODE 4410-09-P



                                                  15632                         Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices

                                                  DEPARTMENT OF JUSTICE                                   DEPARTMENT OF JUSTICE

                                                  Drug Enforcement Administration                         Drug Enforcement Administration                                      Controlled substance                 Schedule

                                                                                                          [Docket No. DEA–392]                                        Thebaine (9333) ...........................   II
                                                  [Docket No. DEA–392]                                                                                                Opium tincture (9630) ..................      II
                                                                                                          Bulk Manufacturer of Controlled                             Oxymorphone (9652) ...................        II
                                                  Bulk Manufacturer of Controlled                         Substances Application: Penick
                                                  Substances Application: Patheon                         Corporation                                                   The company plans to manufacture
                                                  Pharmaceuticals, Inc.                                                                                               the above-listed controlled substances
                                                                                                          ACTION:    Notice of application.                           as bulk controlled substance
                                                  ACTION:   Notice of application.                                                                                    intermediates for distribution to its
                                                                                                          DATES:  Registered bulk manufacturers of                    customers.
                                                  DATES:  Registered bulk manufacturers of                the affected basic classes, and
                                                                                                                                                                        Dated: March 9, 2015.
                                                  the affected basic class and applicants                 applicants therefore, may file written
                                                                                                                                                                      Joseph T. Rannazzisi,
                                                  therefore may file written comments or                  comments on or objections to the
                                                                                                          issuance of the proposed registration in                    Deputy Assistant Administrator.
                                                  objections to the issuance of the                                                                                   [FR Doc. 2015–06734 Filed 3–23–15; 8:45 am]
                                                  proposed registration in accordance                     accordance with 21 CFR 1301.33(a) on
                                                  with 21 CFR 1301.33(a) on or before                     or before May 26, 2015.                                     BILLING CODE 4410–09–P

                                                  May 26, 2015.                                           ADDRESSES: Written comments should
                                                                                                          be sent to: Drug Enforcement
                                                  ADDRESSES:   Written comments should                    Administration, Attention: DEA Federal                      LIBRARY OF CONGRESS
                                                  be sent to: Drug Enforcement                            Register Representative/ODW, 8701
                                                  Administration, Attention: DEA Federal                                                                              Copyright Royalty Board
                                                                                                          Morrissette Drive, Springfield, Virginia
                                                  Register Representative/ODW, 8701                       22152. Request for hearings should be                       [Docket No. 14–CRB–0006 DART SR (CO/
                                                  Morrissette Drive, Springfield, Virginia                sent to: Drug Enforcement                                   FA) 2013]
                                                  22152. Request for hearings should be                   Administration, Attention: Hearing
                                                  sent to: Drug Enforcement                               Clerk/LJ, 8701 Morrissette Drive,                           Distribution of the 2013 Digital Audio
                                                  Administration, Attention: Hearing                      Springfield, Virginia 22152.                                Recording Technology Royalty Funds
                                                  Clerk/LJ, 8701 Morrissette Drive,
                                                  Springfield, Virginia 22152.                            SUPPLEMENTARY INFORMATION: The                              AGENCY:  Copyright Royalty Board,
                                                                                                          Attorney General has delegated his                          Library of Congress.
                                                  SUPPLEMENTARY INFORMATION:      The                     authority under the Controlled                              ACTION: Notice announcing
                                                  Attorney General has delegated his                      Substances Act to the Administrator of                      commencement of proceeding with
                                                  authority under the Controlled                          the Drug Enforcement Administration                         request for Petitions to Participate and
                                                  Substances Act to the Administrator of                  (DEA), 28 CFR 0.100(b). Authority to                        comments on intention to conduct
                                                  the Drug Enforcement Administration                     exercise all necessary functions with                       paper proceeding.
                                                  (DEA), 28 CFR 0.100(b). Authority to                    respect to the promulgation and
                                                  exercise all necessary functions with                   implementation of 21 CFR part 1301,                         SUMMARY:    The Copyright Royalty Board
                                                  respect to the promulgation and                         incident to the registration of                             is announcing the commencement of a
                                                  implementation of 21 CFR part 1301,                     manufacturers, distributors, dispensers,                    proceeding to determine the distribution
                                                  incident to the registration of                         importers, and exporters of controlled                      of the digital audio recording
                                                  manufacturers, distributors, dispensers,                substances (other than final orders in                      technology royalty fees in the 2013
                                                  importers, and exporters of controlled                  connection with suspension, denial, or                      Sound Recordings Fund (Copyright
                                                  substances (other than final orders in                  revocation of registration) has been                        Owners and Featured Recording Artists
                                                  connection with suspension, denial, or                  redelegated to the Deputy Assistant                         Subfunds). The Board is also
                                                  revocation of registration) has been                    Administrator of the DEA Office of                          announcing the date by which a party
                                                  redelegated to the Deputy Assistant                     Diversion Control (‘‘Deputy Assistant                       who wishes to participate in this
                                                  Administrator of the DEA Office of                      Administrator’’) pursuant to section 7 of                   proceeding must file its Petition to
                                                  Diversion Control (‘‘Deputy Assistant                   28 CFR part 0, appendix to subpart, R.                      Participate and the accompanying $150
                                                  Administrator’’) pursuant to section 7 of                  In accordance with 21 CFR                                filing fee, if applicable. Finally, the
                                                  28 CFR part 0, appendix to subpart R.                   1301.33(a), this is notice that on                          Board is announcing the Copyright
                                                    In accordance with 21 CFR                             February 26, 2014, Penick Corporation,                      Royalty Judges’ intention to conduct a
                                                  1301.33(a), this is notice that on                      33 Industrial Park Road, Pennsville,                        paper proceeding.
                                                  December 11, 2014, Patheon                              New Jersey 08070, applied to be                             DATES: Petitions to Participate,
                                                  Pharmaceuticals, Inc., 2110 E. Galbraith                registered as a bulk manufacturer of the                    comments on the intention to conduct a
                                                  Road, Cincinnati, Ohio 45237 applied to                 following basic classes of controlled                       paper proceeding, and applicable filing
                                                  be registered as a bulk manufacturer of                 substances:                                                 fee are due no later than April 23, 2015.
                                                  gamma hydroxybutyric acid (2010), a                                                                                 ADDRESSES: An original, five copies, and
                                                  basic class of nonnarcotic controlled                                                                               an electronic copy in Portable
                                                  substance in schedule I.                                        Controlled substance                    Schedule    Document Format (PDF) on a CD of the
                                                    The company plans to manufacture                                                                                  Petition to Participate, along with the
                                                                                                          Cocaine (9041) .............................    II
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  the listed controlled substance for                                                                                 $150 filing fee, if applicable, may be
                                                                                                          Codeine (9050) .............................    II          delivered to the Copyright Royalty
                                                  distribution to its customers.                          Dihydrocodeine (9120) .................         II          Board by either mail or hand delivery.
                                                    Dated: March 9, 2015.                                 Oxycodone (9143) ........................       II
                                                                                                          Hydromorphone (9150) ................           II
                                                                                                                                                                      Petitions to Participate and the $150
                                                  Joseph T. Rannazzisi,                                                                                               filing fee may not be delivered by an
                                                                                                          Ecgonine (9180) ...........................     II
                                                  Deputy Assistant Administrator.                         Hydrocodone (9193) .....................        II          overnight delivery service other than the
                                                  [FR Doc. 2015–06733 Filed 3–23–15; 8:45 am]             Morphine (9300) ...........................     II          U.S. Postal Service Express Mail. If by
                                                  BILLING CODE 4410–09–P                                  Oripavine (9330) ...........................    II          mail (including overnight delivery),


                                             VerDate Sep<11>2014   01:09 Mar 24, 2015   Jkt 235001   PO 00000   Frm 00085    Fmt 4703    Sfmt 4703       E:\FR\FM\24MRN1.SGM    24MRN1



Document Created: 2015-12-18 11:44:56
Document Modified: 2015-12-18 11:44:56
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of application.
DatesRegistered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before May 26, 2015.
FR Citation80 FR 15632 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR